| Literature DB >> 21481044 |
T Leclerc1, C Thepenier, P Jault, E Bey, J Peltzer, M Trouillas, P Duhamel, L Bargues, M Prat, M Bonderriter, J-J Lataillade.
Abstract
Severe burns remain a life-threatening local and general inflammatory condition often with serious sequelae, despite remarkable progress in their treatment over the past three decades. Cultured epidermal autografts, the first and still most up-to-date cell therapy for burns, plays a key role in that progress, but drawbacks to this need to be reduced by using cultured dermal-epidermal substitutes. This review focuses on what could be, in our view, the next major breakthrough in cell therapy of burns - use of mesenchymal stromal cells (MSCs). After summarizing current knowledge, including our own clinical experience with MSCs in the pioneering field of cell therapy of radiation-induced burns, we discuss the strong rationale supporting potential interest in MSCs in treatment of thermal burns, including limited but promising pre-clinical and clinical data in wound healing and acute inflammatory conditions other than burns. Practical options for future therapeutic applications of MSCs for burns treatment, are finally considered.Mesh:
Year: 2011 PMID: 21481044 PMCID: PMC6496832 DOI: 10.1111/j.1365-2184.2010.00727.x
Source DB: PubMed Journal: Cell Prolif ISSN: 0960-7722 Impact factor: 6.831